TOFAJAK is a Janus kinase inhibitor that blocks enzymes responsible for inflammation. The drug helps reduce symptoms of inflammation, such as pain, swelling, and stiffness in joints, and is used for the treatment of various autoimmune diseases, such as rheumatoid arthritis and osteoarthritis. It is recommended for patients who do not respond well to traditional treatments.
The product is used for:
Rheumatoid arthritis
Osteoarthritis
Inflammatory bowel diseases (e.g., Crohn's disease)
Psoriasis
TOFAJAK is taken orally, typically 1 tablet (5 mg) twice a day, depending on the patient's condition and doctor's prescription. The drug can be taken with or without food. The dosage may be adjusted based on the patient's response and condition.
Contraindications:
Hypersensitivity to the components of the product
Severe liver diseases
Pregnancy and breastfeeding (under medical supervision)
Active infectious diseases
Side Effects:
Nausea, headache
Gastrointestinal disturbances (diarrhea, dyspepsia)
Increased liver and kidney enzyme levels
Infectious complications (e.g., cold, urinary tract infections)
